BRIEF — Fujifilm to spend four billion yen on manufacturing facility

Japanese conglomerate Fujifilm Corporation is to spend around four billion yen ($40 million) building a new manufacturing facility for its group company, Toyama Chemical.

The facility will be used to manufacture liposome drugs utilizing proprietary technologies such as the anti-cancer agent, FF-10832, for the use of clinical trials and commercial marketing.

Construction will begin in September 2018, and the facility is scheduled to begin operations, in line with GMP standards, in February 2020.